ZA985993B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA985993B
ZA985993B ZA985993A ZA985993A ZA985993B ZA 985993 B ZA985993 B ZA 985993B ZA 985993 A ZA985993 A ZA 985993A ZA 985993 A ZA985993 A ZA 985993A ZA 985993 B ZA985993 B ZA 985993B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
diabetic
treatment
inhibitor
relates
Prior art date
Application number
ZA985993A
Other languages
English (en)
Inventor
Frank Carey
David Patrick Tuffin
Norman Eugene Cameron
Mary Anne Cotter
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ZA985993B publication Critical patent/ZA985993B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA985993A 1997-07-08 1998-07-07 Pharmaceutical compositions ZA985993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714274.9A GB9714274D0 (en) 1997-07-08 1997-07-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA985993B true ZA985993B (en) 1999-01-18

Family

ID=10815469

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985993A ZA985993B (en) 1997-07-08 1998-07-07 Pharmaceutical compositions

Country Status (28)

Country Link
US (1) US6337327B1 (pt)
EP (1) EP0991424B1 (pt)
JP (1) JP2002509540A (pt)
KR (1) KR20010015551A (pt)
CN (1) CN1186097C (pt)
AT (1) ATE205402T1 (pt)
AU (1) AU746211B2 (pt)
BR (1) BR9810570A (pt)
CA (1) CA2292451A1 (pt)
CZ (1) CZ290276B6 (pt)
DE (1) DE69801661T2 (pt)
DK (1) DK0991424T3 (pt)
ES (1) ES2163283T3 (pt)
GB (1) GB9714274D0 (pt)
HK (1) HK1028876A1 (pt)
HU (1) HU224009B1 (pt)
ID (1) ID24597A (pt)
IL (1) IL133004A (pt)
NO (1) NO20000045D0 (pt)
NZ (1) NZ501165A (pt)
PL (1) PL337925A1 (pt)
PT (1) PT991424E (pt)
RU (1) RU2216354C2 (pt)
SK (1) SK122000A3 (pt)
TR (1) TR199903026T2 (pt)
UA (1) UA64761C2 (pt)
WO (1) WO1999002189A1 (pt)
ZA (1) ZA985993B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
WO2001064205A2 (en) * 2000-03-02 2001-09-07 The Institutes For Pharmaceutical Discovery, Llc Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2005503378A (ja) * 2001-08-06 2005-02-03 ジエノメツド・エル・エル・シー Ａｃｅの過剰に関連する疾患の治療方法及び組成物
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
WO2003046165A1 (en) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
US20150197536A1 (en) * 2012-07-28 2015-07-16 The Regents Of The University Of Colorado, A Body Corporate Compounds reducing the production of sorbitol in the eye and methods of using the same
CN103063794B (zh) * 2012-12-24 2014-08-06 扬子江药业集团南京海陵药业有限公司 一种依帕司他片的含量检测控制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications

Also Published As

Publication number Publication date
WO1999002189A1 (en) 1999-01-21
KR20010015551A (ko) 2001-02-26
DE69801661T2 (de) 2002-07-04
RU2216354C2 (ru) 2003-11-20
DK0991424T3 (da) 2001-12-03
AU8229698A (en) 1999-02-08
CN1186097C (zh) 2005-01-26
CN1261804A (zh) 2000-08-02
HK1028876A1 (en) 2001-03-09
ES2163283T3 (es) 2002-01-16
SK122000A3 (en) 2000-06-12
CA2292451A1 (en) 1999-01-21
HUP0002644A2 (hu) 2000-12-28
NZ501165A (en) 2001-06-29
IL133004A (en) 2004-12-15
GB9714274D0 (en) 1997-09-10
BR9810570A (pt) 2000-09-19
ID24597A (id) 2000-07-27
EP0991424A1 (en) 2000-04-12
AU746211B2 (en) 2002-04-18
NO20000045L (no) 2000-01-06
DE69801661D1 (de) 2001-10-18
PL337925A1 (en) 2000-09-11
UA64761C2 (uk) 2004-03-15
ATE205402T1 (de) 2001-09-15
TR199903026T2 (xx) 2000-04-21
CZ290276B6 (cs) 2002-06-12
CZ200017A3 (cs) 2000-05-17
EP0991424B1 (en) 2001-09-12
IL133004A0 (en) 2001-03-19
US6337327B1 (en) 2002-01-08
PT991424E (pt) 2002-02-28
HU224009B1 (hu) 2005-04-28
JP2002509540A (ja) 2002-03-26
NO20000045D0 (no) 2000-01-06

Similar Documents

Publication Publication Date Title
IL133004A0 (en) Pharmaceutical compositions comprising an aldose inhibitor and an ace inhibitor
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
IL151313A0 (en) Lipase containing pharmaceutical compositions
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
YU30700A (sh) Kombinacija inhibitora aldozo reduktaze i inhibitora glikogen fosforilaze
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
AU2386201A (en) Substituted sapogenins and their use
MXPA02002118A (es) Composiciones que contienen productos leguminosos.
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
AU2119200A (en) Medicament
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
AU9534398A (en) Novel pharmaceutical composition
MY133969A (en) Indoloquinazolinones
MXPA02002119A (es) Productos leguminosos.
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
YU68900A (sh) Kombinacije inhibitora protein farnesiltransferaze i hmg coa reduktaze i njihova upotreba u tretmanu raka
SI1347764T1 (sl) Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
GB9923858D0 (en) Antimicrobial compositions
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
GR3034142T3 (en) Composition for the treatment or prevention of herpes